• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Forum Markets Incorporated

    7/9/26 4:02:18 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $FRMM alert in real time by email
    DEFA14A 1 ea0297517-defa14a_forum.htm SOLICITING MATERIAL PURSUANT TO 240.14A-12
     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

     

     

    SCHEDULE 14A

     

    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934 

    (Amendment No. )

     

     

     

    Filed by the Registrant ☒  
    Filed by party other than the registrant ☐  

     

    Check the appropriate box:

     

    ☐ Preliminary Proxy Statement
       
    ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
       
    ☐ Definitive Proxy Statement
       
    ☐ Definitive Additional Materials
       
    ☒ Soliciting Material under § 240. 14a-12

     

    FORUM MARKETS, INCORPORATED
    (Name of Registrant as Specified In Its Charter)

     

     

    (Name of Person(s) Filing Proxy Statement, if Other Than The Registrant)

     

    Payment of Filing Fee (Check the appropriate box):

     

    ☒ No fee required

     

    ☐ Fee paid previously with preliminary materials.

     

    ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

     

     

     

     

     

    Your Vote Counts! FORUM MARKETS, INCORPORATED 2875 SOUTH OCEAN BLVD. SUITE 100 PALM BEACH, FL 33480 FORUM MARKETS, INCORPORATED 2026 Annual Meeting Vote by August 18, 2026 11:59 PM ET You invested in FORUM MARKETS, INCORPORATED and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on August 19, 2026. Get informed before you vote View the Notice and Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to August 5, 2026. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com , (2) call 1 - 800 - 579 - 1639 or (3) send an email to sendmaterial@proxyvote.com . If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. STOCKHOLDER MEETING REGISTRATION: To vote and/or attend the meeting, go to “shareholder meeting registration” link at www.proxyvote.com . Vote Virtually at the Meeting* August 19, 2026 10:00 A.M. Eastern Time Virtually at: www.virtualshareholdermeeting.com/FRMM2026 *Please check the meeting materials for any special requirements for meeting attendance. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # T01439 - P55242

     

     

    Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. Prefer to receive an email instead? While voting on www.ProxyVote.com , be sure to click “Delivery Settings”. For 1. Election of Class II Directors Nominees: 1) McAndrew Rudisill 2) Ryan Smith 3) Jason New For 2. To approve an advisory resolution on Named Executive Officer compensation. For 3. To ratify the appointment of M&K CPAs, PLLC, as Forum Markets, Incorporated’s independent registered accounting firm for the fiscal year ending December 31, 2026 . NOTE: Such other business as may properly come before the Annual Meeting, or any adjournments or postponements thereof. Voting Items Board Recommends T01440 - P55242

     

    Get the next $FRMM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FRMM

    DatePrice TargetRatingAnalyst
    4/7/2026$5.00Speculative Buy
    The Benchmark Company
    More analyst ratings

    $FRMM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Lomashuk Konstantin sold $16,141 worth of shares (2,562 units at $6.30) (SEC Form 4)

    4 - FORUM MARKETS Inc (0001690080) (Issuer)

    7/20/26 9:26:28 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Lomashuk Konstantin sold $20,846 worth of shares (3,387 units at $6.15) (SEC Form 4)

    4 - FORUM MARKETS Inc (0001690080) (Issuer)

    7/14/26 4:25:34 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Lomashuk Konstantin sold $30,477 worth of shares (4,802 units at $6.35) (SEC Form 4)

    4 - FORUM MARKETS Inc (0001690080) (Issuer)

    7/9/26 4:44:25 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FRMM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Forum Markets Acquires Aircraft Engine for Approximately $12 Million, Advances Plan to Expand Aviation Portfolio to Five Engines

    Company Expects to Complete Acquisition of an Additional Engine in the Coming Weeks; Most Widely Used Engine Platform Offers Scale and Repeatable Deal Flow PALM BEACH, Fla., July 16, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM), a digital asset platform modernizing capital markets through the tokenization of real-world assets, today announced that it has closed on the acquisition of a commercial aircraft engine for approximately $12 million in cash, expanding the company's aviation portfolio to four income-generating engines under long-term lease to major U.S. airlines. Forum is in the process of finalizing the purchase of an a

    7/16/26 8:00:00 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Announces Initiation of Analyst Coverage by Sidoti & Company with $10.00 Price Target

    PALM BEACH, Fla., May 29, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM), a digital asset platform modernizing capital markets through the tokenization of real-world assets, today announced that Sidoti & Company, LLC has initiated coverage of the company's common stock with a Not Rated (NR) classification and a price target of $10.00 per share. Sidoti is the third research firm to initiate coverage of Forum in 2026. The research report, authored by Brendan McCarthy, CFA, was published on May 28, 2026. Sidoti's initiation highlights Forum's position as an early mo

    5/29/26 8:00:00 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum to Present at Benchmark's Digital Assets Summit on May 27

    PALM BEACH, Fla., May 19, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM) ("Forum"), a digital asset platform modernizing capital markets through the tokenization of real-world assets, today announced that McAndrew Rudisill, chairman and CEO, and John Kristoff, senior vice president, corporate communications and investor relations, are expected to participate in the Benchmark Digital Assets Summit on Wednesday, May 27, 2026, in New York.  The company will participate in the panel discussion "How Tokenization Is Reshaping Private and Public Markets" at 3:00 PM EDT

    5/19/26 8:00:00 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FRMM
    SEC Filings

    View All

    Forum Markets Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FORUM MARKETS Inc (0001690080) (Filer)

    7/16/26 8:00:14 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEFA14A filed by Forum Markets Incorporated

    DEFA14A - FORUM MARKETS Inc (0001690080) (Filer)

    7/9/26 4:02:18 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Forum Markets Incorporated

    DEF 14A - FORUM MARKETS Inc (0001690080) (Filer)

    7/8/26 4:11:15 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FRMM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    The Benchmark Company initiated coverage on Forum Markets with a new price target

    The Benchmark Company initiated coverage of Forum Markets with a rating of Speculative Buy and set a new price target of $5.00

    4/7/26 8:46:27 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FRMM
    Leadership Updates

    Live Leadership Updates

    View All

    Forum Appoints Robert Spake as General Counsel

    PALM BEACH, Fla., March 3, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM), a digital asset platform modernizing capital markets through the tokenization of real-world assets on Ethereum, today announced the appointment of Robert Spake as the company's general counsel. Spake's deep legal expertise in capital markets, tokenization, and regulatory compliance strengthens Forum's leadership team and sharpens its focus on launching compliant, institutionally structured real-world asset products within evolving regulatory frameworks.  "Robert joins Forum at a pivotal mo

    3/3/26 9:00:00 AM ET
    $ETHZ
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FRMM
    Financials

    Live finance-specific insights

    View All

    Forum Markets Acquires Aircraft Engine for Approximately $12 Million, Advances Plan to Expand Aviation Portfolio to Five Engines

    Company Expects to Complete Acquisition of an Additional Engine in the Coming Weeks; Most Widely Used Engine Platform Offers Scale and Repeatable Deal Flow PALM BEACH, Fla., July 16, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM), a digital asset platform modernizing capital markets through the tokenization of real-world assets, today announced that it has closed on the acquisition of a commercial aircraft engine for approximately $12 million in cash, expanding the company's aviation portfolio to four income-generating engines under long-term lease to major U.S. airlines. Forum is in the process of finalizing the purchase of an a

    7/16/26 8:00:00 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Reports First Quarter 2026 Financial Results

    PALM BEACH, Fla., May 14, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM) ("Forum" or the "Company"), a digital asset platform modernizing capital markets through the tokenization of real-world assets, today reported financial results for the first quarter ended March 31, 2026. "Forum continues to execute against our core strategy of building a platform centered on originating, structuring, and tokenizing institutional-grade, yield-generating assets," said McAndrew Rudisill, chairman and CEO. "We've expanded our origination capabilities with our entry into AI infr

    5/14/26 8:00:00 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Reports Fourth Quarter and Full Year 2025 Financial Results

    Company Introduces 2026 Guidance as RWA Tokenization Platform Begins to Scale PALM BEACH, Fla., March 31, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM) ("Forum" or the "Company"), a digital asset platform modernizing capital markets through the tokenization of real-world assets on Ethereum, today reported financial results for the fourth quarter and full year ended December 31, 2025. "In less than a year, Forum has moved from concept to execution: from building the infrastructure, establishing key partnerships, and validating our technology, to generating revenu

    3/31/26 9:00:00 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care